(Q39351512)

11 September 2017

title

Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses (English)

1 reference

11 September 2017

A S Beare

1

1 reference

11 September 2017

G C Schild

series ordinal

2

1 reference

11 September 2017

J W Craig

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 October 1975

1 reference

11 September 2017

1 reference

11 September 2017

volume

2

1 reference

11 September 2017

issue

7938

1 reference

11 September 2017

page(s)

729-732

1 reference

Recombinant influenza-A viruses as live vaccines for man. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990720-5

7 January 2021

Segregation of antigenic and biological characteristics during influenza virus recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990720-5

7 January 2021

Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990720-5

7 January 2021

Investigetion into the attenuation of influenza viruses by serial passage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990720-5

7 January 2021

An improved assay for the infectivity of in influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990720-5

7 January 2021

Nonlinkage of neurovirulence exclusively to viral hemagglutinin or neuraminidase in genetic recombinants of A-NWS (HON1) influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990720-5

7 January 2021

Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990720-5

7 January 2021

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990720-5

7 January 2021

Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990720-5

7 January 2021

Recombination of influenza A viruses of human and animal origin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990720-5

7 January 2021

10.1016/S0140-6736(75)90720-5

Identifiers

DOI

1 reference

11 September 2017

1 reference